Esab [ESAB] vs CompoSecure [CMPO] Detailed Stock Comparison
Esab
NYSE
Loading...
CompoSecure
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Esab wins in 8 metrics, CompoSecure wins in 11 metrics, with 0 ties. CompoSecure appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Esab | CompoSecure | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.32 | 13.73 | CompoSecure |
| Price-to-Book Ratio | 3.26 | -20.49 | CompoSecure |
| Debt-to-Equity Ratio | 55.25 | 0.00 | CompoSecure |
| PEG Ratio | 20.66 | 15.51 | CompoSecure |
| EV/EBITDA | 14.70 | 32.98 | Esab |
| Profit Margin (TTM) | 9.36% | -28.15% | Esab |
| Operating Margin (TTM) | 15.44% | 17.95% | CompoSecure |
| EBITDA Margin (TTM) | 15.44% | 17.95% | CompoSecure |
| Return on Equity | 14.87% | 37.45% | CompoSecure |
| Return on Assets (TTM) | 6.74% | 11.33% | CompoSecure |
| Free Cash Flow (TTM) | $303.62M | $121.11M | Esab |
| Dividend Yield | 0.27% | N/A | N/A |
| 1-Year Return | 17.45% | 103.36% | CompoSecure |
| Price-to-Sales Ratio (TTM) | 2.46 | 6.70 | Esab |
| Enterprise Value | $7.70B | $1.79B | Esab |
| EV/Revenue Ratio | 2.81 | 6.68 | Esab |
| Gross Profit Margin (TTM) | 37.18% | 48.06% | CompoSecure |
| Revenue per Share (TTM) | $45 | $3 | Esab |
| Earnings per Share (Diluted) | $4.57 | $-1.32 | Esab |
| Beta (Stock Volatility) | 1.24 | 0.97 | CompoSecure |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Esab vs CompoSecure Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Esab | -4.08% | -14.79% | -12.13% | -11.75% | -9.54% | -6.08% |
| CompoSecure | 21.74% | 26.39% | 21.40% | 51.64% | 43.45% | 38.14% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Esab | 17.45% | 145.54% | 122.26% | 122.26% | 122.26% | 122.26% |
| CompoSecure | 103.36% | 203.81% | 114.04% | 114.04% | 114.04% | 114.04% |
Performance & Financial Health Analysis: Esab vs CompoSecure
| Metric | ESAB | CMPO |
|---|---|---|
| Market Information | ||
| Market Cap | $6.75B | $1.79B |
| Market Cap Category | Mid cap | Small cap |
| 10 Day Avg. Volume | 597,260 | 1,128,020 |
| 90 Day Avg. Volume | 366,457 | 897,627 |
| Last Close | $111.13 | $17.53 |
| 52 Week Range | $93.13 - $135.97 | $7.13 - $17.54 |
| % from 52W High | -18.27% | -0.06% |
| All-Time High | $135.97 (Nov 04, 2024) | $17.54 (Aug 08, 2025) |
| % from All-Time High | -18.27% | -0.06% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | -0.41% |
| Quarterly Earnings Growth | -0.19% | -0.42% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | -0.28% |
| Operating Margin (TTM) | 0.15% | 0.18% |
| Return on Equity (TTM) | 0.15% | 0.37% |
| Debt to Equity (MRQ) | 55.25 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $34.10 | $-1.04 |
| Cash per Share (MRQ) | $4.25 | $0.05 |
| Operating Cash Flow (TTM) | $309.95M | $66.60M |
| Levered Free Cash Flow (TTM) | $197.44M | $159.49M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.27% | N/A |
| Last 12-Month Dividend | $0.32 | $0.00 |
Valuation & Enterprise Metrics Analysis: Esab vs CompoSecure
| Metric | ESAB | CMPO |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.32 | 13.73 |
| Forward P/E | 20.66 | 15.51 |
| PEG Ratio | 20.66 | 15.51 |
| Price to Sales (TTM) | 2.46 | 6.70 |
| Price to Book (MRQ) | 3.26 | -20.49 |
| Market Capitalization | ||
| Market Capitalization | $6.75B | $1.79B |
| Enterprise Value | $7.70B | $1.79B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.81 | 6.68 |
| Enterprise to EBITDA | 14.70 | 32.98 |
| Risk & Other Metrics | ||
| Beta | 1.24 | 0.97 |
| Book Value per Share (MRQ) | $34.10 | $-1.04 |
Financial Statements Comparison: Esab vs CompoSecure
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ESAB | CMPO |
|---|---|---|
| Revenue/Sales | $715.59M | $59.82M |
| Cost of Goods Sold | $449.54M | $31.08M |
| Gross Profit | $266.05M | $28.75M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $110.48M | $6.04M |
| EBITDA | $129.84M | $7.81M |
| Pre-Tax Income | $88.10M | $33.65M |
| Income Tax | $18.28M | $27.00M |
| Net Income (Profit) | $68.10M | $21.49M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ESAB | CMPO |
|---|---|---|
| Cash & Equivalents | $258.22M | $9.51M |
| Total Current Assets | $1.34B | $10.83M |
| Total Current Liabilities | $686.47M | $47.09M |
| Long-Term Debt | $1.12B | $0 |
| Total Shareholders Equity | $2.11B | $-87.31M |
| Retained Earnings | $720.47M | $-293.59M |
| Property, Plant & Equipment | $415.45M | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ESAB | CMPO |
|---|---|---|
| Operating Cash Flow | $41.08M | $9.71M |
| Capital Expenditures | $-2.69M | $0 |
| Free Cash Flow | $28.12M | $2.62M |
| Debt Repayment | $-2.50M | $0 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ESAB | CMPO |
|---|---|---|
| Shares Short | 1.06M | 10.69M |
| Short Ratio | 3.13 | 13.38 |
| Short % of Float | 0.03% | 0.22% |
| Average Daily Volume (10 Day) | 597,260 | 1,128,020 |
| Average Daily Volume (90 Day) | 366,457 | 897,627 |
| Shares Outstanding | 60.52M | 100.46M |
| Float Shares | 56.70M | 36.10M |
| % Held by Insiders | 0.06% | 0.57% |
| % Held by Institutions | 0.98% | 0.60% |
Dividend Analysis & Yield Comparison: Esab vs CompoSecure
| Metric | ESAB | CMPO |
|---|---|---|
| Last 12-Month Dividend | $0.32 | $0.00 |
| Last 12-Month Dividend Yield | 0.27% | N/A |
| 3-Year Avg Annual Dividend | $0.23 | $0.08 |
| 3-Year Avg Dividend Yield | 0.09% | 4.58% |
| 3-Year Total Dividends | $0.70 | $0.25 |
| Ex-Dividend Date | Apr 04, 2025 | May 17, 2024 |